THIAZOL-5-YLMETHYL (2S,3R,5R)-3-HYDROXY-5-((S)-2-(3-((2-ISOPROPYLTHIAZOL-4-YL)METHYL)-3-METHYLUREIDO(-3-METHYLBUTANAMIDO)-1,6-DIPHENYLHEXAN-2-YLCARBAMATE
UNII 2TJ3KVE30D
Substance Identification & Data
This profile provides standardized clinical and technical data for Thiazol-5-ylmethyl (2s,3r,5r)-3-hydroxy-5-((s)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido(-3-methylbutanamido)-1,6-diphenylhexan-2-ylcarbamate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2TJ3KVE30D.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1414933-82-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C37H48N6O5S2 NCDNCNXCDXHOMX-PHTQWASBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Thiazol-5-ylmethyl (2s,3r,5r)-3-hydroxy-5-((s)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido(-3-methylbutanamido)-1,6-diphenylhexan-2-ylcarbamate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.